CNXU

Conexeu Sciences Inc. Common Stock
NASDAQHEALTHCAREBIOTECHNOLOGY

Key Statistics

Market Cap
$302.10M
P/E Ratio
EPS
$-0.26
Beta
52W High
$18.79
52W Low
$10.87
50-Day MA
$13.93
200-Day MA
$13.93
Dividend Yield
Profit Margin
0.00%
Forward P/E
PEG Ratio

About Conexeu Sciences Inc. Common Stock

Conexeu Sciences Inc. (Ticker: CNXU) is a dynamic biotech firm dedicated to advancing healthcare through innovative solutions in diagnostics and therapeutics. The company focuses on harnessing cutting-edge technology to develop products that improve patient outcomes while reducing healthcare costs. With a strong emphasis on research and development, Conexeu is positioned at the forefront of critical medical advancements, making it a compelling prospect for institutional investors seeking exposure to the growing biotechnology sector. Through strategic partnerships and a robust pipeline, the company aims to deliver transformative health solutions that address unmet medical needs.

Official WebsiteUSAFY End: October

Fundamentals

Revenue (TTM)0
Gross Profit (TTM)0
EBITDA$-5.31M
Operating Margin0.00%
Return on Equity0.00%
Return on Assets0.00%
Revenue/Share (TTM)$0.00
Book Value$0.34
Price-to-Book44.88
Price-to-Sales (TTM)
EV/Revenue-
EV/EBITDA
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)0.00%
Shares Outstanding$26.76M
Float$20.09M
% Insiders40.98%
% Institutions0.00%

Historical Volatility

HV 10-Day
HV 20-Day
HV 30-Day
HV 60-Day
HV Rank

More HEALTHCARE Stocks

Data last updated: 6/15/2026